Dow Up 0.64% Nasdaq Up 0.45%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.96 Up 0.20(3.52%) 11:43AM EST - Nasdaq Real Time Price
Prev Close:5.76
Open:5.93
Bid:5.95 x 200
Ask:5.96 x 3200
1y Target Est:11.33
Beta:3.84
Next Earnings Date:N/A
Day's Range:5.77 - 6.13
52wk Range:3.11 - 7.82
Volume:2,056,952
Avg Vol (3m):4,555,280
Market Cap:734.39M
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXUp 3.52%734.39M
ABTUp 0.07%65.97B
GSKUp 0.47%112.03B
RHHBYDown 0.61%254.47B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Dec-14) :0.23
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-3.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback